EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 151 filers reported holding EPIZYME INC in Q3 2020. The put-call ratio across all filers is 2.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $120,000 | -54.7% | 13,766 | -38.1% | 0.01% | -67.4% |
| Q3 2020 | $265,000 | +24.4% | 22,251 | +29.4% | 0.04% | +22.9% |
| Q1 2019 | $213,000 | -38.3% | 17,201 | -32.4% | 0.04% | -32.7% |
| Q2 2018 | $345,000 | -24.8% | 25,453 | +5.6% | 0.05% | -29.7% |
| Q3 2017 | $459,000 | +341.3% | 24,104 | +136.1% | 0.07% | +164.3% |
| Q2 2016 | $104,000 | – | 10,208 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |